New answer by Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center (August 1, 2022)
I think the shortest answer is, "Do what you do for your patients with high-risk cytogenetics." If you ask 4 different myeloma specialists, you'll get 4 different answers: VRd...